Discover more near‑term opportunities with better event intelligence.
Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Rallies
Acquired Company
Evoke Pharma
Bilbao
Solana BeachFinancial ServicesFinanceLendingBiotechnologyHealth CarePharmaceuticalDescription
Rallies Inc. is set to acquire Evoke Pharma, Inc. in a cash merger transaction. Shareholders of Evoke Pharma will receive USD 11.00 per share. This acquisition emphasizes cash conversion rather than product expansion or new forecasts. Evoke Pharma focuses on treatments for diabetic gastroparesis in women.
Fundz sees it the moment Rallies makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Evoke Pharma?
Evoke Pharma was acquired by Rallies, based in Bilbao. The deal was reported on September 29, 2026. Rallies Inc. is a financial services company that provides insights and analysis on market trends and corporate actions. They focus on delivering comprehensive research to aid investors in decision-making. Rallies is privately held and operates in Financial Services.
When did Rallies acquire Evoke Pharma?
Rallies's acquisition of Evoke Pharma was reported on September 29, 2026. Rallies Inc. is set to acquire Evoke Pharma, Inc. in a cash merger transaction. Shareholders of Evoke Pharma will receive USD 11.00 per share. This acquisition emphasizes cash conversion rather than product expansion or new forecasts. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Evoke Pharma do?
Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI (metoclopramide) nasal spray. It is privately held, operating in Biotechnology, and is based in Solana Beach.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.